Working… Menu

The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03722992
Recruitment Status : Active, not recruiting
First Posted : October 29, 2018
Last Update Posted : May 30, 2019
Information provided by (Responsible Party):
TriHealth Inc.

Brief Summary:
This is a prospective cohort study to investigate differences in the bladder environment (i.e. urinary microbiome) amongst women with interstitial cystitis (IC) before and after undergoing mindfulness-based stress reduction (MBSR) treatment, including yoga and meditation practices.

Condition or disease Intervention/treatment Phase
Interstitial Cystitis Other: MBSR Not Applicable

Detailed Description:

Interstitial cystitis (IC), or Painful Bladder Syndrome (PBS) is a debilitating condition of the bladder that is estimated to affect 3-8 million women in the United States. The pathophysiology of the disease is poorly understood, and thus treatment modalities and treatment efficacy vary widely. Lately, much attention has shifted toward investigating how the bladder 'environment' differs amongst women with IC compared to those who do not suffer from IC.

Mindfulness-based stress reduction (MBSR), a complementary alternative medicine (CAM)-based therapy, is a standardized program including components of meditation and yoga. Recent studies show that MBSR improves symptoms in the IC patient population.

The purpose of this study is to compare measurable differences in the urinary microbiome among women with IC before and after MBSR treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 19 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effects of Mindfulness-based Stress Reduction on the Urinary Microbiome in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Actual Study Start Date : March 7, 2019
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Mindfulness Cohort
Mindfulness-based stress reduction (MBSR) treatment group
Other: MBSR
Guided yoga and meditation practices

Primary Outcome Measures :
  1. Difference in the urinary microbiome before and after MBSR treatment [ Time Frame: Before intervention and after completion of the intervention, up to 9 weeks ]
    Urinary microbiome sequencing analysis will be performed by Resphera Biosciences Laboratory

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Adults 18 years of age or older
  • English-speaking
  • Established patient of Cincinnati Urogynecology Associates, TriHealth Inc.
  • Current diagnosis of IC/PBS, as defined by the American Urological Association (AUA)
  • Negative urinalysis or urine culture within 2 months of enrollment
  • Currently undergoing first or second-line treatment for IC, as defined by the AUA
  • Willingness to participate in study

Exclusion Criteria:

  • Non-English speaking
  • Unwillingness to participate in study
  • Pregnancy or breastfeeding
  • Physical or mental impairment that would affect the subject's ability to participate in the MBSR treatment, including patients with Dementia, Parkinsonism, or those who have impaired mobility or hearing
  • Current or expected prolonged catheterization
  • Expected travel or surgery that would hinder the ability to attend all eight MBSR sessions
  • Undergoing third-, fourth-, fifth-, or sixth-line treatment for IC as defined by the AUA
  • Subjects on antibiotics currently or prior use within one week of consenting

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03722992

Layout table for location information
United States, Ohio
TriHealth - Cincinnati Urogynecology Associates
Cincinnati, Ohio, United States, 45220
Sponsors and Collaborators
TriHealth Inc.
Layout table for investigator information
Principal Investigator: Rachel Pauls, MD TriHealth - Cincinnati Urogynecology Associates

Layout table for additonal information
Responsible Party: TriHealth Inc. Identifier: NCT03722992     History of Changes
Other Study ID Numbers: 18-056
First Posted: October 29, 2018    Key Record Dates
Last Update Posted: May 30, 2019
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Cystitis, Interstitial
Urinary Bladder Diseases
Urologic Diseases